1
/
of
0
FDA Adalimumab Cases with Primary Sclerosing Cholangitis – Multiple Case IDs
FDA Adalimumab Cases with Primary Sclerosing Cholangitis – Multiple Case IDs
Regular price
$89.00 USD
Regular price
Sale price
$89.00 USD
Unit price
/
per
Original Request: I'm looking to request cases of patients who were diagnosed with primary sclerosing cholangitis while taking Adalimumab. 07120614, 07499131, 18820124, 18026941, 19686644, 14490314 ,08100911, 20003748, 15877029, 17393739, 20496270, 13415092.
Tags: Pharma, Adverse Event, 2025
Tags: Pharma, Adverse Event, 2025
Couldn't load pickup availability
- Status: Pending Fast-Track Request
- Delivery: Approximately 1 to 2 weeks when the FOIA office is operating at regular capacity
NOTE: This document is not currently in our library. Upon purchase, we will request the document from the FDA FOIA office. Learn more about Fast-Track Requests here.
View full details